Hubert Lincet

3.2k total citations · 1 hit paper
35 papers, 2.3k citations indexed

About

Hubert Lincet is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hubert Lincet has authored 35 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 18 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Hubert Lincet's work include Cancer, Hypoxia, and Metabolism (18 papers), Cancer-related Molecular Pathways (10 papers) and Mitochondrial Function and Pathology (9 papers). Hubert Lincet is often cited by papers focused on Cancer, Hypoxia, and Metabolism (18 papers), Cancer-related Molecular Pathways (10 papers) and Mitochondrial Function and Pathology (9 papers). Hubert Lincet collaborates with scholars based in France, China and Lebanon. Hubert Lincet's co-authors include Philippe Icard, Marco Alifano, Zherui Wu, Ludovic Fournel, Diana Farhat, Jean‐Marc Steyaert, Laurent Poulain, S. Shulman, Antoine Coquerel and Pascal Gauduchon and has published in prestigious journals such as Blood, Oncogene and Trends in Biochemical Sciences.

In The Last Decade

Hubert Lincet

35 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

How the Warburg effect supports aggressiveness and drug resistance of cancer cells?

2018 449 citations Philippe Icard, S. Shulman et al. Drug Resistance Updates profile →

Peers

Hubert Lincet

ONCOL

PRM

IMMUN

Alba Luengo United States

Ferdinando Chiaradonna Italy

Maria Peiris‐Pagès United Kingdom

Wei-Qun Ding United States

Jiyeon Kim United States

Abderrahmane Kaidi United Kingdom

Zhao Chen China

Wenjing Du China

Luciano Vellón United States

Ashley Solmonson United States

Alba Luengo United States

Hubert Lincet

1.8k ×1.2

1.4k ×1.3

396 ×0.9

ONCOL

170 ×0.9

PRM

172 ×1.0

IMMUN

Citations per year, relative to Hubert Lincet Hubert Lincet (= 1×) peers Alba Luengo

Countries citing papers authored by Hubert Lincet

Since Specialization

Citations

This map shows the geographic impact of Hubert Lincet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Lincet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Lincet more than expected).

Fields of papers citing papers by Hubert Lincet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hubert Lincet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Lincet. The network helps show where Hubert Lincet may publish in the future.

Co-authorship network of co-authors of Hubert Lincet

This figure shows the co-authorship network connecting the top 25 collaborators of Hubert Lincet. A scholar is included among the top collaborators of Hubert Lincet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hubert Lincet. Hubert Lincet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Icard, Philippe, Luca Simula, Ludovic Fournel, et al.. (2022). The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications. Drug Resistance Updates. 63. 100852–100852. 43 indexed citations

Icard, Philippe, Mauro Loi, Zherui Wu, et al.. (2020). Metabolic Strategies for Inhibiting Cancer Development. Advances in Nutrition. 12(4). 1461–1480. 21 indexed citations

Icard, Philippe, Hubert Lincet, Zherui Wu, et al.. (2020). The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. Biochimie. 180. 169–177. 103 indexed citations

Farhat, Diana, Sophie Léon, Sandra E. Ghayad, et al.. (2020). Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation. British Journal of Cancer. 122(6). 885–894. 24 indexed citations

Farhat, Diana & Hubert Lincet. (2019). Lipoic acid a multi-level molecular inhibitor of tumorigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1873(1). 188317–188317. 45 indexed citations

Icard, Philippe, Ludovic Fournel, Zherui Wu, Marco Alifano, & Hubert Lincet. (2019). Interconnection between Metabolism and Cell Cycle in Cancer. Trends in Biochemical Sciences. 44(6). 490–501. 233 indexed citations

Icard, Philippe, Zherui Wu, Ludovic Fournel, et al.. (2019). ATP citrate lyase: A central metabolic enzyme in cancer. Cancer Letters. 471. 125–134. 168 indexed citations

Icard, Philippe, S. Shulman, Diana Farhat, et al.. (2018). How the Warburg effect supports aggressiveness and drug resistance of cancer cells?. Drug Resistance Updates. 38. 1–11. 449 indexed citations breakdown →

Icard, Philippe, et al.. (2015). Lipoic acid decreases Mcl-1, Bcl-xL and up regulates Bim on ovarian carcinoma cells leading to cell death. Journal of Ovarian Research. 8(1). 36–36. 27 indexed citations

10.

Lincet, Hubert & Philippe Icard. (2014). How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?. Oncogene. 34(29). 3751–3759. 156 indexed citations

11.

Lincet, Hubert, et al.. (2013). Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells. Journal of Ovarian Research. 6(1). 72–72. 35 indexed citations

12.

Icard, Philippe & Hubert Lincet. (2012). A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1826(2). 423–433. 99 indexed citations

13.

Icard, Philippe, Laurent Poulain, & Hubert Lincet. (2011). Understanding the central role of citrate in the metabolism of cancer cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1825(1). 111–116. 129 indexed citations

14.

Lincet, Hubert, Blandine Guével, Charles Pineau, et al.. (2011). Comparative 2D-DIGE proteomic analysis of ovarian carcinoma cells: Toward a reorientation of biosynthesis pathways associated with acquired platinum resistance. Journal of Proteomics. 75(4). 1157–1169. 18 indexed citations

15.

Roué, Gaël, Vianney Pichereau, Hubert Lincet, Dolors Colomer, & Brigitte Sola. (2008). Cyclin D1 mediates resistance to apoptosis through upregulation of molecular chaperones and consequent redistribution of cell death regulators. Oncogene. 27(36). 4909–4920. 49 indexed citations

16.

Lincet, Hubert, Paulo Marcelo, Natacha Heutte, et al.. (2007). A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment. PROTEOMICS. 7(22). 4090–4101. 20 indexed citations

17.

Villedieu, Marie, Marie-Hélène Louis, Soizic Dutoit, et al.. (2007). Absence of Bcl-xL down-regulation in response to cisplatin is associated with chemoresistance in ovarian carcinoma cells☆. Gynecologic Oncology. 105(1). 31–44. 39 indexed citations

18.

Lincet, Hubert, E. Deslandes, Marie Hubert‐Roux, et al.. (2006). Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1‐R10. PROTEOMICS. 6(19). 5183–5192. 54 indexed citations

19.

Lincet, Hubert, Laurent Poulain, Jean-Serge Rémy, et al.. (2000). The p21 cip1/waf1 cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Letters. 161(1). 17–26. 84 indexed citations

20.

Poulain, Laurent, Hubert Lincet, E. Deslandes, et al.. (1998). Acquisition of chemoresistance in a human ovarian carcinoma cell line is linked to a defect in cell cycle control. International Journal of Cancer. 78(4). 454–463. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact